Cytocare 532

Key Features of Cytocare 532

Micro-injections of the resorbable implant Revitacare's CYTOCARE 532, which contains hyaluronic acid and rejuvenating complex, are used to inject the formula into the face's superficial dermis, where it can successfully treat fine lines and wrinkles, dry skin, and a lack of density and brightness. CT50's advanced rejuvenating blend and 32 mg of hyaluronic acid were used to diminish wrinkles. Dermal regeneration and extensive re-densification, which also results in appropriate moisture, brightness, and luminosity, can prevent premature aging and delay the emergence of wrinkles.

CYTOCARE 532 is an innovative range of resorbable implants that contains a rejuvenating complex and hyaluronic acid. This one-of-a-kind formulation is intended to be injected into the face's superficial dermis via micro-injections, targeting fine lines and wrinkles, dehydrated skin, and a lack of density and brightness. 
With its powerful combination of a CT50 rejuvenating formula and 32 mg of hyaluronic acid, CYTOCARE 532 not only helps fight premature aging, delaying the appearance of wrinkles, but also promotes intense re-densification and dermal regeneration. 
Furthermore, CYTOCARE 532 provides high hydration, giving the skin a beautiful glow and radiance.

The benefits of Cytocare 532

• fight premature aging
• reduce wrinkles and fine lines
• promote intense re-densification
• stimulate dermal regeneration
• hydrate the skin